Andrew Pusar, an associate in Goodwin’s Technology Companies and Life Sciences Group, concentrates in general corporate and securities law and has significant experience in capital markets transactions, mergers and acquisitions, venture capital financings, SEC compliance and corporate governance. Mr. Pusar represents public and private emerging growth technology and life science companies as well as venture capital funds and investment banks focusing on technology and life science companies. He has experience advising companies through every stage of the corporate life cycle – from initial financing through successful initial public offering or acquisition.

Areas of Practice




Mr. Pusar’s transactional experience includes the following venture capital financings, capital markets transactions and mergers and acquisitions:

Venture Financings

  • Kensho Technologies in its Series B financing with participation by S&P, Goldman Sachs, General Catalyst, Morgan Stanley, Bank of America and JPMorgan
  • Codiak BioSciences in its Series C financing with participation by ARCH Venture Partners, Flagship Pioneering and Fidelity Management and Research Company
  • Glossier in its Series B financing led by Institutional Venture Partners, with participation from Index Ventures, Thrive Capital and Forerunner Ventures
  • Anchor FM in its Series A financing led by Google Ventures and Accel
  • Precision Biologics in its Series A financing by an affiliate of NantWorks
  • Orchard Platform in its Series B financing led by Thrive Capital, Spark Capital and Canaan Partners

Capital Markets

  • CRISPR Therapeutics AG in its initial public offering
  • Represented the underwriters, including RBC, in Altair Engineering’s initial public offering
  • Represented investment bankers, including Cowen, in G1 Therapeutics’ initial public offering
  • Represented William Blair in a follow-on offering by USA Technologies
  • Represented Cowen in follow-on offerings by Albireo Pharma
  • Represented the underwriter in Oncobiologics’ initial public offering

Mergers and Acquisitions

  • Interactions in its acquisition of Digital Roots
  • Nalari Health in its sale to BehaveCare
  • Catheter Connections in its sale to Merit Medical Systems
Professional Activities

Mr. Pusar is a frequent lecturer at Columbia Business School and Columbia Law School on venture financings and other elements of start-up law.

Professional Experience

Prior to joining Goodwin, Mr. Pusar was an associate in the New York office of Davis Polk & Wardwell LLP.

In The News







J.D., 2012
Columbia Law School

(Harlan Fiske Stone scholar)

B.A., 2009
Harvard University



New York
New Jersey
Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers